Therefore, it is presumed that due to the high frequency of protective TT genotype and the low frequency of risk GG genotype, the IL28B gene polymorphism may play a quiet role in predicting treatment response of Chinese hepatitis C patients treated with PEG-IFN/RBV (15). This evidence concerns the gene IFNA1 and hepatitis C virus infection.